CURRENT DEVELOPMENT OF PODOPHYLLOTOXINS

被引：27

作者：

CANETTA, R

HILGARD, P

FLORENTINE, S

BEDOGNI, P

LENAZ, L

机构：

[1] BRISTOL MYERS CO,INT DIV,CLIN ANTI CANC RES,345 PK AVE,NEW YORK,NY 10154

[2] BRISTOL MYERS INT CORP,B-1170 BRUSSELS,BELGIUM

来源：

关键词：

D O I：

10.1007/BF00254528

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：93 / 98

页数：6

共 63 条

[51] SCHABEL FM, 1979, CANCER TREAT REP, V63, P1459
[52] SEEBER S, 1981, P AM ASSOC CANC RES, V22, P257
[53] SIEROCKI JS, 1979, CANCER TREAT REP, V63, P1593
[54] SNODGRASS W, 1980, P AM ASSOC CANC RES, V21, P333
[55] SOLOWAY MS, 1980, CISPLATIN CURRENT ST, P345
[56] 4'-DEMETHYL-EPIPODOPHYLLOTOXIN THENYLIDENE GLUCOSIDE (VM 26), A PODOPHYLLUM COMPOUND WITH A NEW MECHANISM OF ACTION
STAHELIN, H
[J]. EUROPEAN JOURNAL OF CANCER, 1970, 6 (04) : 303 - +
[57] ACTIVITY OF A NEW GLYCOSIDIC LIGNAN DERIVATIVE (VP 16-213) RELATED TO PODOPHYLLOTOXIN IN EXPERIMENTAL TUMORS
STAHELIN, H
[J]. EUROPEAN JOURNAL OF CANCER, 1973, 9 (03) : 215 - 221
[58] ANALYSIS OF THE ANTI-CANCER DRUGS VP-16-213 AND VM-26 AND THEIR METABOLITES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
STRIFE, RJ
JARDINE, I
COLVIN, M
[J]. JOURNAL OF CHROMATOGRAPHY, 1980, 182 (02): : 211 - 220
[59] VALDIVIESO M, 1979, P AM ASSOC CANC RES, V20, P383
[60] WILLIAMS SD, 1980, CANCER, V46, P2154, DOI 10.1002/1097-0142(19801115)46:10<2154::AID-CNCR2820461008>3.0.CO